CareTrust REIT: An Acquisition Titan That's Still A Buy For Long-Term Investors
CareTrust REIT remains a buy due to strong fundamentals, impressive acquisitions, and a recent price pullback, offering long-term growth potential. The REIT's acquisition spree, totaling nearly $1 billion in 2023, has significantly boosted FFO and revenue, showcasing robust growth despite economic challenges. CareTrust's fortress balance sheet, low leverage, and potential credit rating upgrade position it for further upside and acquisition opportunities.
Down -6.3% in 4 Weeks, Here's Why CareTrust REIT (CTRE) Looks Ripe for a Turnaround
CareTrust REIT (CTRE) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
CareTrust REIT: Strong Fundamentals And Growth Potential - Buy
I rate CareTrust REIT a buy due to its strong fundamentals, consistent financial performance, and promising growth prospects driven by acquisitions and demographic trends. CTRE's financials are impressive, with consistent revenue growth, stable operating expenses, and a strong balance sheet, justifying its premium valuation. The company's robust market position, diversified portfolio, and extensive geographical presence provide stability and growth opportunities, particularly in high-demand states like California and Texas.
Forget The Election, REITs Win No Matter What
The election is on the 5th of November. We don't think the outcome will matter for REITs. Macroeconomics trumps politics. We explain why.
CareTrust REIT, Inc. (CTRE) Q3 2024 Earnings Call Transcript
CareTrust REIT, Inc. (NYSE:CTRE ) Q3 2024 Earnings Conference Call October 30, 2024 1:00 PM ET Company Participants Lauren Beale - Senior Vice President and Controller Dave Sedgwick - President and Chief Executive Officer Bill Wagner - Chief Financial Officer James Callister - Chief Investment Officer Conference Call Participants Jonathan Hughes - Raymond James John Pinkowski - Wells Fargo Austin Wurschmidt - KeyBanc Capital Markets Michael Carroll - RBC Capital Markets Robin Haneland - BMO Capital Markets Wes Golladay - Baird Rich Anderson - Wedbush Operator Thank you for standing by. My name is Prima [Ph] and I will be your conference operator today.
CareTrust REIT (CTRE) Reports Q3 Earnings: What Key Metrics Have to Say
The headline numbers for CareTrust REIT (CTRE) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
CareTrust REIT (CTRE) Q3 FFO Match Estimates
CareTrust REIT (CTRE) came out with quarterly funds from operations (FFO) of $0.38 per share, in line with the Zacks Consensus Estimate. This compares to FFO of $0.35 per share a year ago.
All You Need to Know About CareTrust REIT (CTRE) Rating Upgrade to Buy
CareTrust REIT (CTRE) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
CareTrust Buys 4 Nursing Facilities in Mid-Atlantic for $74.7M
CTRE acquires four skilled nursing facilities in Mid-Atlantic to grow its healthcare portfolio.
CareTrust REIT: Looking For Healthcare Exposure? You Should Consider This REIT
CareTrust REIT is a top choice for healthcare exposure as well as REIT exposure, with strong growth potential and an impressive 1H performance. CTRE's robust balance sheet and strategic acquisitions have driven significant share price appreciation, outperforming peers and the broader market. Despite economic risks, CareTrust REIT's strong fundamentals and healthcare sector stability justify a continued buy rating, with an upside price target of $35.49.
CareTrust REIT Surges: Riding High On Skilled Nursing Strength
CareTrust REIT has shown strong fundamentals with high rent collection, a 9.9% yield on new investments, and a robust balance sheet with low leverage. The company is well-positioned for growth, benefiting from favorable Medicare rate increases and acquisition opportunities in the skilled nursing sector. Despite these strengths, CTRE's current P/FFO of 20.2 suggests a 'Hold' rating, making it less attractive for value investors at its current price.
CareTrust REIT (CTRE) Is Up 4.96% in One Week: What You Should Know
Does CareTrust REIT (CTRE) have what it takes to be a top stock pick for momentum investors? Let's find out.
